68Ga-PET/CT PSMA用于确定原发性放疗后生化复发前列腺癌的疾病模式
这项回顾性单中心队列研究纳入2014年7月至2018年6月间因原发性放疗后PSA升高而接受68Ga-PSMA PET/CT的连续男性患者276例,中位PSA为3.60 ng/mL,总体疑似复发检出率为86.3%,局部复发最常见(56.9%),在未达Phoenix标准的患者中75.3%的扫描提示复发。作者认为需要前瞻性结局研究来确定早期识别局部复发能否通过增加挽救性局部治疗改善结局。
要点
- 总体疑似复发检出率为86.3%,局部复发最常见,占56.9%(157/276)。
- 未达Phoenix标准(PSA nadir+2)的73例中,75.3%(55/73)扫描提示复发,52.1%为可挽救病变。
- 髂动脉周围区域是最常见的淋巴结转移部位,55.6%的复发位于髂区。
核心结论
- 68Ga-PSMA PET/CT常在达到公认的Phoenix定义(PSA nadir+2)之前就识别出疑似复发疾病。
- 需要前瞻性结局研究来确定早期识别局部复发能否通过增加挽救性局部治疗的使用来改善结局,以及早期识别转移性疾病能否通过及时启动多模式治疗来改善结局。
研究设计与样本
- 回顾性单三级机构队列研究,纳入2014年7月至2018年6月间连续男性患者,这些患者因原发性放疗后PSA升高而接受68Ga-PSMA PET/CT。
- 共276例患者符合纳入标准,中位PSA为3.60 ng/mL。
- 主要结局指标是确定扫描前PSA与识别提示复发性前列腺癌的PSMA avid疾病概率之间的关系。
主要发现
- 疑似复发性前列腺癌的总体检出率为86.3%。
- 局部复发是最常见部位,发生于56.9%(157/276)的男性,孤立性局部复发占32.6%(90/276)。
- 在未达Phoenix标准的男性中,75.3%(55/73)的扫描提示复发疾病,其中52.1%的男性为可挽救疾病。
- 髂动脉周围区域是最常见的淋巴结转移区域,55.6%的复发发生于髂区。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: 68Ga-PET/CT PSMA scan is being increasingly used for the staging of biochemically recurrent disease. Early identification of recurrent disease after radiotherapy is important in considering suitability for early salvage therapy to improve prognosis. The aim is to identify patterns of suspected prostate cancer recurrence in relation to post-radiotherapy PSA levels, especially below the accepted Phoenix definition of PSA failure (PSA nadir + 2). METHODS: This was a retrospective single tertiary institution cohort study of consecutive men between July 2014 and June 2018 who received a 68Ga-PSMA PET/CT for elevated PSA levels following radiotherapy as primary treatment of prostate cancer. The primary outcome measure was to determine the relationship between pre-scan PSA and the probability of identifying PSMA-avid disease suggestive of recurrent prostate cancer. RESULTS: Two hundred and seventy-six patients met criteria for inclusion. The median PSA was 3.60 ng/mL. The overall detection rate for suspected recurrent prostate cancer was 86.3%. Local recurrence was the most common site, occurring in 56.9% (157/276) of men, with isolated local recurrence in 32.6% (90/276). A total of 75.3% (55/73) of men below Phoenix criteria had scans suggestive of recurrent disease, with 52.1% of men having salvageable disease. The regions surrounding the iliac arteries were the most common areas of nodal metastatic disease, with 55.6% of recurrence occurring in the iliac regions. CONCLUSIONS: 68Ga-PSMA PET/CT frequently identifies suspected recurrent disease prior to the accepted Phoenix definition of PSA nadir +2. Prospective outcome studies are required to determine if early identification of local recurrence improves outcomes by increasing the use of salvage local treatments and whether earlier identification of metastatic disease may improve outcomes with prompt initiation of multimodality therapies.
引用
- Raveenthiran S, Yaxley J, Gianduzzo T, et al. The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy. Prostate Cancer Prostatic Dis. 2019. PMID: 31363165. doi:10.1038/s41391-019-0163-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。